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Clinical Case Report
ABSTRACT
Retroperitoneal liposarcomas are rare tumors arising from the soft tissue of the retroperitoneum and are of mesenchymal 
cell origin. They can reach a large size prior to causing symptoms and generally have a poor prognosis. We present the 
case of a 93-year-old lady presenting with a large retroperitoneal liposarcoma at the site of a previous colonic anastomosis 
for the adenocarcinoma treatment. It caused minimal symptoms initially, but surgical resection was undertaken when 
the tumor was found to be growing significantly in size. However, due to the tumor’s location and its invasion into 
surrounding structures, the resection was not feasible and subsequently abandoned. A retroperitoneal liposarcoma arising 
from the site of a previous colonic resection has not been previously described. A review of the diagnosis and current 
management of these lesions is also given. 
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INTRODUCTION
Retroperitoneal soft tissue sarcomas (STSs) are rare, 
accounting for 10-15% of all soft tissue sarcomas.1,2 Of 
these STSs, retroperitoneal liposarcomas (RPLs) are the 
most common subtype.3 These lesions often cause minimal 
or no symptoms and can reach a significant size, growing 
undetected in the retroperitoneal space before invading 
or compressing surrounding organs, eventually leading 
to clinical symptoms. This makes them challenging to 
diagnose and subsequently treat effectively.
Most RPLs arise de novo but can occur in a pre-
existing lipoma. There are no established causative 
factors but risk factors include ionizing radiation, 
chemotherapy and some genetic conditions. Trauma, 
although suspected is not a known risk factor.
We hereby present a case of an RPL occurring at the 
anastomosis site of a previous left hemicolectomy in a 
nonagenarian, which has not previously been reported on.
CASE REPORT
A n  8 8 - y e a r - o l d  f e m a l e  u n d e r w e n t  a 
left hemicolectomy for the resection of colonic 
adenocarc inoma.  The  h i s to logy  o f  the  l e f t 
hemicolectomy showed moderately differentiated 
colonic adenocarcinoma, with 2 of 6 lymph node 
involvement i.e. T3N1. She did not receive any adjuvant 
therapy. Her recovery was uncomplicated, and she 
was eventually discharged to her general practitioner 
for ongoing annual surveillance. She had a follow-up 
colonoscopy, which did not demonstrate any recurrence.
Five years later, at the age of 93, she presented to 
our service for investigation of a new mass in the left 
upper quadrant detected on a surveillance abdominal 
CT. She had only mild non-specific upper abdominal 
discomfort, and no bowel changes were noted. 
She also had a history of atrial fibrillation, for which she 
was on apixaban. No abdominal mass was palpable, 
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and the examination was otherwise unremarkable. 
The CEA level had been stable and consistently less 
than 1ug/L (normal non-smoker < 5ug/L). On the 
abdominal CT, a 4.7 x 3.0cm soft-tissue density mass 
was evident anterior to the left kidney, adjacent to 
the tail of the pancreas and the previous colonic 
anastomosis. (Figure 1A)
A core biopsy of the lesion was performed and 
showed an atypical spindle cell lesion, thought initially 
to represent a desmoid or low-grade sarcomatous 
lesion. It was unable to be characterized further. Given 
the lack of clinical symptoms, the small size of the 
lesion, and her advanced age, a decision was made for 
observation only with interval imaging. Throughout the 
observation period, the patient remained functionally 
very well.
However, over a 12-month period, the lesion 
showed progressive enlargement, up to 12.7 x 8.6cm 
(Figure 1B and 1C).
The patient began to complain of the worsening 
of the abdominal discomfort and fullness. After an 
extended discussion with the patient and her family, 
a decision was made to perform a laparotomy in an 
attempt to excise the lesion. Intraoperatively, the tumor 
was found to be adherent and inseparable to the nearby 
structures suggesting local invasion. These included the 
previous colonic anastomosis, spleen, tail of pancreas 
and left kidney. The procedure was abandoned due to 
the potential morbidity of multi-visceral resection to 
achieve complete surgical excision. Surgical biopsies 
were performed, which demonstrated a moderately 
cellular tumor composed of atypical spindle cells 
within a collagenous stroma (Figure 2A), reactivity 
for MDM2 on immunohistochemistry (Figure 2B) and 
MDM2 amplification by fluorescence in situ hybridization 
(Figure 2C), consistent with dedifferentiated liposarcoma. 
The patient was discharged for supportive care and 
symptom management.
Figure 1. Abdominal CT – A – (axial view) showing a 4.7 x 3.0cm soft-tissue density mass anterior to the left kidney, 
adjacent to the tail of the pancreas and the previous colonic anastomosis at the splenic flexure; B – (axial view) 
showing the rapid expanding tumor, 12.7 x 8.6cm, adherent to the nearby structures; C – (coronal view) showing 
the rapid expanding tumor, 12.7 x 8.6cm, adherent to the nearby structures.
Figure 2. Photomicrographs of the tumor. A – showing atypical spindled cells within a collagenous stroma (H&E, 
x100); B – immunohistochemistry shows diffuse reactivity for MDM2 within tumor cell nuclei (x200); C – Fluorescence 
in situ hybridization for MDM2 (12q15) showing amplification of MDM2 (red signals) in comparison with centromere 
(green signals).
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DISCUSSION
Retroperitoneal liposarcoma is rare and commonly 
occurs in patients between 40 and 60 years old. 
It is thought to originate from primitive mesenchymal 
cells.4 Its exact pathogenesis remains unclear but is 
likely multifactorial. Predisposing factors implicated in 
other soft tissue sarcomas, including genetic alteration, 
exposure to radiation and chemical toxins, trauma, and 
previous surgery, may all play a role.5-7
Causality between trauma and subsequent 
development of tumors, especially those of soft tissue 
origin, has long been suspected. The minimal criteria, 
as suggested by Warren et al.,8 for such association 
include prior integrity of tumor site, significant tissue 
disruption, reasonable time frame following the 
initial injury, and compatibility of tumor type with the 
reparation and regeneration process of the tissue site.
Retroperitoneal STSs in the form of desmoid 
tumors developing after surgery have been well 
described.9-11 A literature review by Shih et al.12 reported 
retroperitoneal desmoid tumors in at least 12 patients 
who fit the above minimal criteria. Each of these 
patients had a variety of intra-abdominal surgeries, 
from retroperitoneal lymph node dissection to total 
gastrectomy for GIST. The average time from the 
previous surgery was 2.3 years, ranging from 11 months 
to 7 years.
Retroperitoneal STSs occurring in previous surgery 
sites can often mimic local recurrence of malignancy 
and pose a challenging diagnostic dilemma. It is 
important to exclude local recurrence using tumor 
markers, endoscopy, and other appropriate imaging 
modalities. On the computed tomography (CT), 
RPLs generally appear as an encapsulated mass, that 
contains variable amounts of fatty and soft tissue. CT is 
most useful in delineating the relationship of adjacent 
structures, assessing local invasion, and checking for 
the presence of metastatic disease.13
In addition, MRI may demonstrate characteristics 
of the mass to distinguish between benign and 
malignant soft-tissue masses. Factors associated with 
malignant lesions are larger tumor size (> 10cm), 
thick septa (> 2mm), and less fat content (less 
than 75%).14 Dedifferentiated RPLs often lack 
macroscopic fat signal intensity. MRI can also assess 
local tumor extent and surrounding edema, which 
can then be factored into treatment approaches. It is 
important to note that the extent of the primary tumor 
can be underappreciated on imaging studies.
Percutaneous biopsy is controversial as historically, 
there has been a fear of tumor seeding of the biopsy 
tract. However, a biopsy is required in cases of 
diagnostic uncertainty or if neoadjuvant treatment is 
to be considered. A core biopsy has been shown to be 
both accurate and safe.15,16
There are five histologic subtypes of liposarcomas: 
(i) well-differentiated, (ii) dedifferentiated, (iii) myxoid, 
(iv) pleomorphic, and (v) liposarcoma, not otherwise 
specified. More than 93% of all RPLs are of the well-
differentiated and dedifferentiated subtypes.17 Well-
differentiated RPLs are characterized by scattered, 
often less than 25%, atypical spindle cells among 
lobules of mature adipocytes showing variation in size. 
Dedifferentiated RPLs comprise a non-lipogenic, often 
spindle cell sarcoma, with heterogeneous appearances, 
which may be associated with a component of well-
differentiated liposarcoma. Both well-differentiated 
and dedifferentiated RPLs are associated with a high 
rate of local recurrence. Unlike well-differentiated RPLs, 
which do not tend to metastasize, dedifferentiated 
RPLs are more aggressive and have a significantly 
higher risk of metastasis.18
Recent advancement in molecular genetics has 
also shed some light on the genes implicated in 
liposarcomas. Among these is the murine double 
minute 2 (MDM2) and CDK4 genes. MDM2 encodes 
a protein that is responsible for the degradation 
of p53, a known tumor suppressor gene, and 
CDK4 encodes an oncoprotein that promotes G1/S 
progression of the cell cycle. Both of these genes 
are characteristically amplified in well-differentiated 
and dedifferentiated RPLs.19 Overexpression of these 
proteins are detected by immunohistochemistry or 
amplification may be detected by fluorescence in-situ 
hybridization and is useful in distinguishing well-
differentiated liposarcomas (WDL) and dedifferentiated 
liposarcoma (DDL) from other benign and malignant 
soft tissue tumors.20
The treatment of choice for non-metastasized 
retroperitoneal soft tissue sarcoma is complete 
surgical excision with negative margins. Complete 
en bloc excision may require adjacent organ and fat 
resection, but even then, surgical margins are often 
narrow.21 Unfortunately, even with complete excision, 
prognosis remains poor, particularly for high-grade 
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RPLs.22 Local recurrence is common and can lead to 
morbidity and mortality.
Preoperative, intraoperative, and postoperative 
radiotherapy (RT) have all been used to treat RPS, but 
their role and effectiveness continue to be debated. 
Preoperative RT tends to be used as the lesion may be 
accurately targeted and help reduce toxicity to nearby 
organs, including bowel that may be displaced by the 
tumor. Furthermore, an unresectable tumor can be 
converted to a potentially resectable one with the 
use of RT.23
STRASS was a randomized multicenter international 
trial24 comparing preoperative RT followed by surgery 
to surgery alone. Initial results failed to demonstrate a 
benefit of preoperative RT for retroperitoneal sarcoma, 
although the final results are pending. Postoperative RT 
following complete gross resection has had no study 
proven value and can be associated with significant 
toxicities.25
Systemic treatments for patients with RPL have 
mainly occurred in the setting of clinical trials and 
are typically reserved for those with high-grade 
tumors. This has been used in both neoadjuvant and 
adjuvant settings, and doxorubicin, ifosfamide, and 
anthracycline-based chemotherapy regimens have 
been used. However, data is limited to small studies, 
and results have been disparate.
A better understanding of molecular genetics has 
also led to promising targeted therapy for RPLs. Among 
others, inhibitors of MDM2 and CDK4, the two most 
commonly amplified oncogenes, showed some early 
promising results.26,27
In the present case, the RPL developed adjacent 
to the previous colonic anastomosis in the left upper 
quadrant and was found to be inseparable from the 
colon and adjacent organs intraoperatively. It is difficult 
to determine whether the sarcoma developed as a 
result of the previous surgery or as a primary entity, 
but its proximity to the previous resection site makes 
the former far more likely. At the time of the left 
hemicolectomy, there would have been the dissection 
of the left colonic and transverse mesentery with a 
breach into the retroperitoneal region. This may have 
triggered an abnormal regeneration process to occur, 
leading to the development of the RPL.
In our patient, stable tumor markers and a 
recent normal colonoscopy was reassuring and ruled 
against local recurrence. A diagnosis of a sarcomatous 
lesion was made after a sample was obtained from 
a core biopsy of the lesion. Watchful waiting with 
surveillance scanning was taken initially as the patient 
was asymptomatic and would be the initial preferred 
approach in a nonagenerian. However, with the 
increasing size of the lesion and increase in discomfort, 
an observational approach was no longer appropriate. 
The decision to proceed to operative intervention 
was challenging but after extensive discussion, the 
patient was agreeable to this, despite her advanced 
age. At operation, the extent of the RPL was certainly 
underappreciated on imaging, which was then 
confirmed to be unresectable due to local invasion.
Decisions such as these in elderly patients are 
indeed challenging and clearly the risks and benefits 
of a major operation need to be carefully balanced 
and explained to the patient. Careful review of the 
imaging may demonstrate signs of local invasion which 
may alter the approach and decision making in these 
complex clinical situations.
CONCLUSION
To our knowledge, this is the first reported case 
in which an RPL developed following previous intra-
abdominal surgery. RPL may mimic local recurrence 
of previous malignancy in this setting. Although rare, 
liposarcoma, and other soft tissue sarcomas, should 
be kept in mind when investigating potential lesions 
in the retroperitoneum, particularly in previous surgery 
settings. Tissue sampling is often required to make the 
diagnosis. Further studies are needed to consolidate 
the link between retroperitoneal liposarcoma and 
previous intra-abdominal surgery. Treatment of 
RPL is multimodal and should ideally take place in 
a multidisciplinary center specializing in sarcoma 
treatment. Complete surgical excision is however, the 
mainstay of treatment.
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